Group One Trading, L.P. Akero Therapeutics, Inc. Transaction History

Group One Trading, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$17.76 - $31.18 $629,680 - $1.11 Million	-35,455 Reduced 93.62%	2,416 $61,000
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $146,267 - $646,891	12,853 Added 51.38%	37,871 $884,000
Q3 2023 Nov 09, 2023	SELL	$41.19 - $52.25 $2.29 Million - $2.9 Million	-55,546 Reduced 68.95%	25,018 $1.27 Million
Q2 2023 Aug 09, 2023	BUY	$36.89 - $56.88 $2.97 Million - $4.57 Million	80,417 Added 54705.44%	80,564 $3.76 Million
Q1 2023 May 12, 2023	SELL	$37.27 - $50.24 $4.64 Million - $6.25 Million	-124,481 Reduced 99.88%	147 $5,000
Q4 2022 Feb 09, 2023	BUY	$33.44 - $54.8 $4.17 Million - $6.83 Million	124,573 Added 226496.36%	124,628 $6.83 Million
Q3 2022 Nov 09, 2022	SELL	$10.15 - $34.05 $7,561 - $25,367	-745 Reduced 93.13%	55 $2,000
Q2 2022 Aug 11, 2022	SELL	$8.0 - $15.01 $68,800 - $129,086	-8,600 Reduced 91.49%	800 $8,000
Q1 2022 May 12, 2022	BUY	$12.97 - $22.26 $121,918 - $209,244	9,400 New	9,400 $133,000
Q2 2021 Aug 10, 2021	SELL	$24.81 - $32.35 $1.09 Million - $1.42 Million	-43,885 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$24.04 - $34.19 $1.05 Million - $1.5 Million	43,819 Added 66392.42%	43,885 $1.27 Million
Q3 2020 Nov 12, 2020	SELL	$30.79 - $39.92 $65,829 - $85,348	-2,138 Reduced 97.01%	66 $2,000
Q2 2020 Aug 13, 2020	SELL	$19.25 - $26.76 $23,812 - $33,102	-1,237 Reduced 35.95%	2,204 $55,000
Q1 2020 May 13, 2020	BUY	$12.8 - $27.05 $44,044 - $93,079	3,441 New	3,441 $73,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.29B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.